Sutro Biopharma (STRO) Enterprise Value (2016 - 2026)
Sutro Biopharma (STRO) posted Enterprise Value of -$141.4 million for Q4 2025, up 15.61% sequentially from -$167.6 million in Q3 2025, and up 55.37% YoY from -$91.0 million in Q4 2024.
Sutro Biopharma (STRO) Enterprise Value (2016 - 2026) Analysis & Trends
Sutro Biopharma has reported Enterprise Value for 10 years, with the latest figure at -$141.4 million in Q4 2025.
- Quarterly Enterprise Value rose 55.37% year-over-year to -$141.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$141.4 million (up 55.37% YoY) and the FY2025 annual result came in at -$141.4 million, up 55.37% from the prior year.
- Enterprise Value grew to -$141.4 million in Q4 2025 per STRO's latest filing, from -$167.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$66.6 million in Q1 2022 and troughed at -$388.3 million in Q3 2024.
- A 5-year average of -$218.5 million and a median of -$212.7 million in 2021 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value soared 69.74% in 2022, then tumbled 277.32% in 2023.
- Over 5 years, Enterprise Value stood at -$160.8 million in 2021, then slumped by 88.08% to -$302.3 million in 2022, then surged by 63.22% to -$111.2 million in 2023, then plunged by 184.96% to -$316.9 million in 2024, then surged by 55.37% to -$141.4 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$141.4 million, -$167.6 million, and -$205.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | -164.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -164.35 Mn |
| Dec 31, 2025 | -141.43 Mn |
| Sep 30, 2025 | -167.59 Mn |
| Jun 30, 2025 | -205.13 Mn |
| Mar 31, 2025 | -248.97 Mn |
| Dec 31, 2024 | -316.90 Mn |
| Sep 30, 2024 | -388.25 Mn |
| Jun 30, 2024 | -375.57 Mn |
| Mar 31, 2024 | -267.60 Mn |
| Dec 31, 2023 | -111.21 Mn |
| Sep 30, 2023 | -115.88 Mn |
| Jun 30, 2023 | -268.44 Mn |
| Mar 31, 2023 | -251.47 Mn |
| Dec 31, 2022 | -302.34 Mn |
| Sep 30, 2022 | -287.34 Mn |
| Jun 30, 2022 | -191.63 Mn |
| Mar 31, 2022 | -66.65 Mn |
| Dec 31, 2021 | -160.76 Mn |
| Sep 30, 2021 | -189.94 Mn |
| Jun 30, 2021 | -91.67 Mn |